Andexxa Will Be a New Reversal Agent for Bleeding Due to Eliquis or Xarelto

Andexxa (an-DEK-sah, inactivated recombinant factor Xa) will be a new IV med to reverse bleeding from Eliquis or Xarelto.

Until now, the only reversal agent for the direct oral anticoagulants was Praxbind (idarucizumab).

But it only reverses Pradaxa (dabigatran).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote